These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1354149

  • 21. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites.
    Bocedi A, Dawood KF, Fabrini R, Federici G, Gradoni L, Pedersen JZ, Ricci G.
    FASEB J; 2010 Apr; 24(4):1035-42. PubMed ID: 19952282
    [Abstract] [Full Text] [Related]

  • 22. Expression of Trypanosoma congolense trypanothione reductase in Escherichia coli: overproduction, purification, and characterization.
    Sullivan FX, Shames SL, Walsh CT.
    Biochemistry; 1989 Jun 13; 28(12):4986-92. PubMed ID: 2669965
    [Abstract] [Full Text] [Related]

  • 23. Inhibitors of trypanothione reductase as potential antitrypanosomal drugs.
    Chan C, Yin H, Garforth J, McKie JH, Jaouhari RA, Douglas KT, Fairlamb AH, Croft SL.
    Biochem Soc Trans; 1995 Nov 13; 23(4):511S. PubMed ID: 8654696
    [No Abstract] [Full Text] [Related]

  • 24. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
    Chan C, Yin H, McKie JH, Fairlamb AH, Douglas KT.
    Amino Acids; 2002 Jun 13; 22(4):297-308. PubMed ID: 12107758
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B, Vázquez K, Mascayano C, Tapia RA, Espinosa V, Soto-Delgado J, Salas CO, Paulino M.
    J Biomol Struct Dyn; 2017 Jun 13; 35(8):1785-1803. PubMed ID: 27232454
    [Abstract] [Full Text] [Related]

  • 29. Trypanothione metabolism and rational approaches to drug design.
    Fairlamb AH.
    Biochem Soc Trans; 1990 Oct 13; 18(5):717-20. PubMed ID: 2083656
    [No Abstract] [Full Text] [Related]

  • 30. The Achilles' heel of trypanosomatids: trypanothione-mediated hydroperoxide metabolism.
    Flohé L.
    Biofactors; 1998 Oct 13; 8(1-2):87-91. PubMed ID: 9699014
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Betraying the parasite's redox system: diaryl sulfide-based inhibitors of trypanothione reductase: subversive substrates and antitrypanosomal properties.
    Stump B, Kaiser M, Brun R, Krauth-Siegel RL, Diederich F.
    ChemMedChem; 2007 Dec 13; 2(12):1708-12. PubMed ID: 17918760
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S, Oufir M, Leroux A, Krauth-Siegel RL, Becker K, Kaiser M, Brun R, Hamburger M, Adams M.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7202-9. PubMed ID: 24080104
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. NADPH-dependent disulphide reductases.
    Krauth-Siegel RL, Jockers-Scherübl MC, Becker K, Schirmer RH.
    Biochem Soc Trans; 1989 Apr 15; 17(2):315-7. PubMed ID: 2666188
    [No Abstract] [Full Text] [Related]

  • 40. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C, Yin H, Garforth J, McKie JH, Jaouhari R, Speers P, Douglas KT, Rock PJ, Yardley V, Croft SL, Fairlamb AH.
    J Med Chem; 1998 Jan 15; 41(2):148-56. PubMed ID: 9457238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.